Search

Your search keyword '"Maruyama D"' showing total 408 results

Search Constraints

Start Over You searched for: Author "Maruyama D" Remove constraint Author: "Maruyama D"
408 results on '"Maruyama D"'

Search Results

1. Search for Cosmic Strings in the GOODS Survey

2. P1220: CHARACTERISTICS OF SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA – A SUPPLEMENTARY ANALYSIS OF JCOG0601

3. Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma

6. Subgroup analysis of elderly patients (pts) with diffuse large B‐cell lymphoma (DLBCL) in the Phase 3 POLARIX study.

7. FIRST‐IN‐HUMAN STUDY OF THE EZH1 AND EZH2 DUAL INHIBITOR VALEMETOSTAT TOSYLATE (DS‐3201B) IN PATIENTS WITH RELAPSED OR REFRACTORY NON‐HODGKIN LYMPHOMAS

8. Effects of oral administration of timothy hay and psyllium on the growth performance and fecal microbiota of preweaning calves

9. Three-dimensional aerodynamic design of low-wave-drag supersonic biplane using inverse problem method

10. Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review

16. CLINICAL OUTCOMES AND DIAGNOSIS-TO-TREATMENT INTERVAL IN PATIENTS WITH NK/T-CELL LYMPHOMA: 7-YEAR FOLLOW-UP OF THE NKEA STUDY

17. PF623 PHASE 1/2 STUDY OF ISATUXIMAB MONOTHERAPY FOR RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA IN JAPANESE PATIENTS

18. PS1259 LONG-TERM FOLLOW-UP OF JCOG0406 STUDY: INTENSIVE IMMUNOCHEMOTHERAPY (R-HIGH CHOP/CHASER) FOLLOWED BY HIGH-DOSE CHEMOTHERAPY (LEED) WITH AUTO-PBSCT IN UNTREATED MANTLE CELL LYMPHOMA

23. LONG-TERM FOLLOW-UP AFTER LOCALIZED RADIOTHERAPY IN PATIENTS WITH TRANSFORMED B-CELL LYMPHOMA TREATED WITH RITUXIMAB-CONTAINING CHEMOTHERAPY

24. Fertility and social reintegration after modified CODOX-M/IVAC with or without rituximab: A questionnaire survey of non-Hodgkin lymphoma

25. ASSESSMENT INDEX OF CLINICAL TRANSFORMATION FROM FOLLICULAR LYMPHOMA (FL) TO DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA

27. Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era

28. 288O Role of FDG-PET/CT and gastrointestinal endoscopy in the staging of diffuse large B-cell lymphoma (DLBCL)

30. t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs

37. Locally Non-centrosymmetric Superconductivity in Multilayer Systems

39. Development of Carbon Rich Spin-on Sidewall Material

40. Cytoreductive Regimen Containing Ranimustine (MCNU), Carboplatin, Etoposide and Cyclophosphamide (MCEC) Before Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) for Relapsed or Refractory Lymphoma

Catalog

Books, media, physical & digital resources